https://openbell.ai/ 2026-09-22T17:36:45.759Z hourly 1.0 https://openbell.ai/support 2026-09-22T17:36:45.759Z monthly 0.7 https://openbell.ai/privacy 2026-09-22T17:36:45.759Z monthly 0.5 https://openbell.ai/terms 2026-09-22T17:36:45.759Z monthly 0.5 https://openbell.ai/feed.json 2026-09-22T17:36:45.759Z hourly 0.8 https://openbell.ai/news/IREN:1790098479306 2026-09-22T17:34:39.306Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With IREN Stock Tuesday? IREN Ltd. (NASDAQ: IREN) stock rose approximately 2% to $48.19 on Tuesday, driven by positive analyst sentiment and the company's expansion into high-margin artificial intelligence cloud infrastructure. The stock is trading above key moving averages, remaining about 13% above its 20-day and 18% above its 50-day averages. Analysts have a Buy consensus rating with an average price target of $77.75, while recent coverage includes a Neutral rating from Rothschild with a $40 forecast and an Outperform rating from Northland Capital Markets with a $99 forecast. https://openbell.ai/news/IMC:1790098476524 2026-09-22T17:34:36.524Z daily 0.9 https://cdn.brandfetch.io/IMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud IMC Rare Earths shares are trading higher after the company announced encouraging test results from its Itarantim rare earths project in Brazil. openbell Financial News https://openbell.ai/news/IREN:1790098470377 2026-09-22T17:34:30.377Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With IREN Stock Tuesday? IREN Ltd. (NASDAQ: IREN) stock increased by approximately 2% on Tuesday, trading at $48.19, bolstered by positive analyst sentiment and the company's expansion into high-margin artificial intelligence cloud infrastructure. The stock remains above key moving averages, with resistance near $49 and support around $41. Analysts maintain a Buy consensus rating, with price forecasts ranging from $40 to $99, reflecting optimism about IREN's strategic shift towards AI workloads and data center expansion. https://openbell.ai/news/IREN:1790098459392 2026-09-22T17:34:19.392Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With IREN Stock Tuesday? IREN Ltd. (NASDAQ: IREN) stock rose approximately 2% to $48.19 on Tuesday, buoyed by positive analyst sentiment and the company's expansion into higher-margin artificial intelligence cloud infrastructure. The stock is trading above key moving averages, with resistance near $49 and support around $41. Analysts have a Buy consensus rating with an average price target of $77.75, while recent upgrades from firms like JPMorgan and Northland Capital Markets reflect optimism about the company's future performance. https://openbell.ai/news/IREN:1790098445767 2026-09-22T17:34:05.767Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With IREN Stock Tuesday? IREN Ltd. (NASDAQ: IREN) stock increased by approximately 2% to $48.19 on Tuesday, buoyed by positive analyst sentiment and the company's expansion into higher-margin artificial intelligence cloud infrastructure. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong technical momentum, with resistance near $49 and support around $41. Analysts maintain a Buy consensus rating with an average price target of $77.75, while recent coverage from Rothschild and Northland Capital Markets has further contributed to the stock's upward momentum. https://openbell.ai/news/IREN:1790098408244 2026-09-22T17:33:28.244Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With IREN Stock Tuesday? IREN Ltd. (NASDAQ: IREN) stock increased by approximately 2% to $48.19 on Tuesday, supported by positive analyst momentum and the company's expansion into high-margin artificial intelligence cloud infrastructure. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, with resistance near $49 and support around $41. Analysts have a Buy consensus rating for IREN, with an average price forecast of $77.75, while recent coverage includes a Neutral rating from Rothschild with a $40 price target and an Outperform rating from Northland Capital Markets with a $99 target. https://openbell.ai/news/APH:1790098362131 2026-09-22T17:32:42.131Z daily 0.9 https://cdn.brandfetch.io/APH/w/400/h/400?c=1idopYfmtR7ZKg8QMud BNP Paribas Maintains Outperform on Amphenol, Raises Price Target to $110 BNP Paribas analyst Andrew Buscaglia has maintained an 'Outperform' rating on Amphenol (NYSE: APH) and raised the price target from $107.5 to $110. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/VICR:1790098260063 2026-09-22T17:31:00.063Z daily 0.9 https://cdn.brandfetch.io/VICR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Reiterates Buy on Vicor, Maintains $375 Price Target Roth Capital analyst Justin Clare has reiterated a Buy rating on Vicor (NASDAQ: VICR) and maintained a price target of $375. This endorsement reflects confidence in the company's performance and potential for growth. https://openbell.ai/news/DOCU:1790097879069 2026-09-22T17:24:39.069Z daily 0.9 https://cdn.brandfetch.io/DOCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of enterprise software companies are trading lower. Investors may be trimming exposure amid e-commerce and payments agreements for Meta's Musa agentic AI assistant, would could lead to lower demand for legacy offerings. openbell Financial News https://openbell.ai/news/SBMT:1790097833242 2026-09-22T17:23:53.242Z daily 0.9 https://cdn.brandfetch.io/SBMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Initiates Coverage On Silver Bow Mining with Buy Rating, Announces Price Target of $11 Roth Capital analyst Mike Niehuser has initiated coverage on Silver Bow Mining (AMEX: SBMT) with a Buy rating. The firm has set a price target of $11 for the company's stock. https://openbell.ai/news/PYPL:1790097804106 2026-09-22T17:23:24.106Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/London--Uk---August-2021-Paypal-Finance-.jpg?width=250&height=187 PayPal Stock Is Rising: What's Going On Today? PayPal Holdings Inc. (NASDAQ: PYPL) shares rose 1.14% to $53.22 following the announcement of a partnership with Meta Platforms Inc. (NASDAQ: META). This collaboration will enable customers to shop and check out using Meta's Muse personal AI agent across PayPal's global merchant network. The partnership aims to enhance the shopping experience by integrating AI-driven transactions, potentially increasing transaction volume for PayPal merchants. https://openbell.ai/news/ZEO:1790097687926 2026-09-22T17:21:27.926Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Stock-Market-Trading-Chart-And-Analyzing.jpg?width=250&height=187 Why Is Zeo Energy Stock Gaining Tuesday? Zeo Energy Corp. (NASDAQ: ZEO) stock rose 42.61% to $0.44 following the announcement of a cooperation agreement with Ewyze Corp. to develop integrated off-grid power and data-center infrastructure, primarily targeting the U.S. market. The partnership aims to address the growing demand for reliable power associated with artificial intelligence and cloud computing, with projects potentially operational within two to three years. Trading volume surged to 367.15 million shares, significantly higher than the 100-day average of approximately 3.83 million shares. https://openbell.ai/news/JPM:1790097660848 2026-09-22T17:21:00.848Z daily 0.9 https://cdn.brandfetch.io/JPM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of financial companies are trading lower. The sector may be under pressure as traders rotate into the tech space after recent e-commerce and payments partnerships with Meta's Muse AI agent threaten to disrupt traditional financial companies. openbell Financial News https://openbell.ai/news/FISN:1790097657013 2026-09-22T17:20:57.013Z daily 0.9 https://cdn.brandfetch.io/FISN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Initiates Coverage On Deep Fission with Buy Rating, Announces Price Target of $18 Roth Capital analyst Craig Irwin has initiated coverage on Deep Fission (NASDAQ: FISN) with a Buy rating. The firm has set a price target of $18 for the stock. https://openbell.ai/news/NFLX:1790097599110 2026-09-22T17:19:59.110Z daily 0.9 https://cdn.brandfetch.io/NFLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud HSBC Downgrades Netflix to Hold, Lowers Price Target to $76 HSBC analyst Mohammed Khallouf has downgraded Netflix (NASDAQ: NFLX) from a Buy to a Hold rating. Additionally, the price target for the stock has been reduced from $96 to $76. https://openbell.ai/news/BCHUSD:1790097339751 2026-09-22T17:15:39.751Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Cryptocurrency-Coins-Displaying-XRP--Sol.jpg?width=250&height=187 Bitcoin Cash, Uniswap Surges as CME Announces New Futures Contracts: What's Going On? Bitcoin Cash (BCH) surged 21% following CME Group's announcement of new futures contracts for BCH and Uniswap (UNI). The contracts are designed to meet institutional demand for regulated trading tools in altcoin markets, offering various contract sizes. Despite the positive market reaction for BCH and UNI, CME Group's shares are reportedly under pressure. The new offerings expand CME's existing suite of crypto derivatives, which already includes Bitcoin, Ethereum, and XRP. https://openbell.ai/news/TWLO:1790097158475 2026-09-22T17:12:38.475Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Portland--Or--Usa---Apr-14--2020-The-Twi.jpg?width=250&height=187 Twilio Stock Jumps As Analysts See AI Agents Dialing Up Growth Twilio Inc. (NYSE: TWLO) shares rose 4.92% to $279.14 following analysts' upgrades to their price forecasts, with Rosenblatt raising its target from $275 to $290 and TD Cowen increasing it from $260 to $300. The company reported second-quarter revenue of $1.50 billion, exceeding estimates, and projected third-quarter revenue between $1.51 billion and $1.52 billion. Analysts noted Twilio's potential growth from AI-driven communications, with a 15% stock gain over the past week as consumer-focused AI agents gain traction. https://openbell.ai/news/EU:1790097099793 2026-09-22T17:11:39.793Z daily 0.9 https://cdn.brandfetch.io/EU/w/400/h/400?c=1idopYfmtR7ZKg8QMud enCore Energy shares are trading higher after a Form 4 filing showed its CEO bought 10,000 shares at an average price of $1.06 each. openbell Financial News https://openbell.ai/news/ZIM:1790096964603 2026-09-22T17:09:24.603Z daily 0.9 https://cdn.brandfetch.io/ZIM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching ZIM Integrated Shipping Services; Traders Circulate Unconfirmed M&A Rumors Suggesting The Co Has Received An Offer For $35/Share openbell Financial News https://openbell.ai/news/ENLV:1790096881076 2026-09-22T17:08:01.076Z daily 0.9 https://cdn.brandfetch.io/ENLV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Enlivex shares are trading lower after the company announced the termination of its agreement to sell 66,666,667 shares to the Rain Foundation in exchange for RAIN tokens. openbell Financial News https://openbell.ai/news/CGNX:1790096859646 2026-09-22T17:07:39.646Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/MA.jpg?width=250&height=187 Cognex Buys Intel-Spun RealSense For $500 Million Cognex Corp. has agreed to acquire RealSense for approximately $500 million, aiming to expand into the robotic perception market, which is projected to grow from $600 million today to $1.6 billion by 2030. Following the announcement, Cognex's stock fell nearly 5%, trading at $59.08. The acquisition will be funded entirely with existing cash and investments, and Cognex plans to implement a $56.5 million employee retention package for RealSense staff. RealSense is expected to generate between $80 million and $90 million in revenue in 2026, reflecting over 50% growth from the previous year. https://openbell.ai/news/SMJF:1790096811832 2026-09-22T17:06:51.832Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session On Tuesday, SMJ International Holdings (AMEX: SMJF) saw its stock increase by 28.4% to $1.4, with a market capitalization of $30.1 million. Epsium Enterprise (NASDAQ: EPSM) also experienced a significant rise of 27.2% to $1.59, bringing its market cap to $16.7 million. Conversely, MKDWell Tech (NASDAQ: MKDW) faced a decline of 16.7% to $1.8, resulting in a market cap of $73.8 million. https://openbell.ai/news/FIRY:1790096811643 2026-09-22T17:06:51.643Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Communication Services Stocks Moving In Tuesday's Intraday Session In Tuesday's trading session, Firy (NYSE:FIRY) shares rose by 19.76% to $12.81, with a market capitalization of $167.0 million. Other notable gainers included Eva Live (NASDAQ:GOAI), which increased by 21.1% to $2.12, and WeShop Holdings (NASDAQ:WSHP), which saw a 15.0% rise to $5.98. Conversely, Treasure Global (NASDAQ:TGL) experienced the largest decline, falling 22.0% to $2.31, with a market cap of $5.7 million. https://openbell.ai/news/JAGX:1790096811460 2026-09-22T17:06:51.460Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Tuesday's Intraday Session On Tuesday, Jaguar Health (NASDAQ:JAGX) saw a significant stock increase of 304.5%, reaching $10.8, with a market cap of $1.1 million. Other notable gainers included Greenland Mines (NASDAQ:GRML), which rose 72.18% to $16.22, and Viking Therapeutics (NASDAQ:VKTX), which increased by 31.51% to $39.6, with a market cap of $3.5 billion. Conversely, Silexion Therapeutics (NASDAQ:SLXN) experienced the largest decline, falling 36.1% to $0.35, while Compass Therapeutics (NASDAQ:CMPX) dropped 26.65% to $1.33. https://openbell.ai/news/ZEO:1790096811267 2026-09-22T17:06:51.267Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Tuesday's Intraday Session On Tuesday, Zeo Energy (NASDAQ: ZEO) saw its stock rise by 38.6% to $0.43, with a market value of $13.0 million. Other notable gainers included Quanome Technologies (NASDAQ: QNME), which increased by 35.74% to $0.87, and Rain Enhancement (NASDAQ: RAIN), which rose by 22.69% to $0.81. Conversely, SOS (NYSE: SOS) experienced the largest decline, falling 31.0% to $0.53, with a market cap of $14.8 million. https://openbell.ai/news/BTC:1790096707074 2026-09-22T17:05:07.074Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Bitcoin-Digital-Cryptocurrency-Losing-Va.jpg?width=250&height=187 ‘Crypto Winter Is Over,’ Fundstrat Says: Why Bitcoin, Ether and Solana ETFs Matter Now U.S. spot Bitcoin ETFs saw significant inflows of $998.9 million on Monday, coinciding with Bitcoin's price surge above $86,000, reaching a peak of $87,360 on Tuesday. Fundstrat's Sean Farrell indicated that this breakout suggests the end of the 'crypto winter,' while Compass Point analyst Ed Engel noted the beginning of a new bull market. Major beneficiaries of the inflows included BlackRock's iShares Bitcoin Trust (IBIT), which has approximately $68 billion in assets, and Fidelity's Wise Origin Bitcoin Fund (FBTC), with around $13.9 billion. Additionally, spot Ether ETFs recorded inflows of about $143.8 million, further signaling a recovery in the crypto market. https://openbell.ai/news/CRCL:1790096572849 2026-09-22T17:02:52.849Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Circle-Internet-Group.jpg?width=250&height=187 Circle, Binance Deepen USDC Ties with $100 Million Investment Circle Internet Group, Inc. has expanded its strategic partnership with Binance through a new five-year commercial agreement and a $100 million equity investment. Binance acquired 1.237 million Circle Class A shares at $80.84 each, which is below the market price prior to the deal. The partnership aims to enhance the promotion and integration of USDC across Binance's platform, while Circle will provide support through its Modular Smart Contract Wallet infrastructure. https://openbell.ai/news/RKTO:1790096535852 2026-09-22T17:02:15.852Z daily 0.9 https://cdn.brandfetch.io/RKTO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rocket One shares are trading higher after the company announced a definitive Membership Interest Purchase Agreement to acquire Tracer Drone Technologies. openbell Financial News https://openbell.ai/news/TPB:1790096202507 2026-09-22T16:56:42.507Z daily 0.9 https://cdn.brandfetch.io/TPB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oppenheimer Maintains Outperform on Turning Point Brands, Lowers Price Target to $90 Oppenheimer analyst Ian Zaffino has maintained an 'Outperform' rating on Turning Point Brands (NYSE: TPB) but has lowered the price target from $130 to $90. This adjustment reflects a change in the analyst's outlook on the company's performance. https://openbell.ai/news/PSKY:1790096147564 2026-09-22T16:55:47.564Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Warsaw--Poland---Feb-10--2026-Mobile-Scr.jpg?width=250&height=187 Why Is Paramount Skydance Stock Gaining Tuesday? Paramount Skydance Corporation (NASDAQ: PSKY) stock increased by approximately 2% on Tuesday, reaching $10.20, following the extension of expiration dates for its exchange and tender offers. This rise comes after the company settled an antitrust lawsuit, allowing it to move forward with its $110 billion acquisition of Warner Bros. Discovery, Inc. Analysts from Morgan Stanley and Citizens have provided positive ratings and raised price forecasts, with Morgan Stanley increasing its target to $11.50. Despite a 45.81% decline over the past year, the stock is showing signs of recovery, trading above its 50-day and 100-day moving averages. https://openbell.ai/news/MSFT:1790095819749 2026-09-22T16:50:19.749Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oppenheimer Maintains Outperform on Microsoft, Raises Price Target to $570 Oppenheimer analyst Brian Schwartz has maintained an 'Outperform' rating on Microsoft (NASDAQ: MSFT) and raised the price target from $515 to $570. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/USO:1790095806096 2026-09-22T16:50:06.096Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud President Trump Says Iran Has Been Talking With Us Even Today; I Think A Settlement Will Be Reached President Trump announced that Iran has been in communication with the U.S., expressing optimism that a settlement will be reached. This statement could have implications for market sentiment and the stock price of USO, which is linked to oil prices influenced by geopolitical developments. No specific financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/LMT:1790095762891 2026-09-22T16:49:22.891Z daily 0.9 https://cdn.brandfetch.io/LMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of aerospace and defense companies are trading lower amid multiple catalysts that indicate de-escalation in the Middle East. Reports suggested Iran would open the Strait of Hormuz in seven days if the U.S. took certain steps, and President Trump said he expects an agreement with Iran after the U.S. midterm elections. openbell Financial News https://openbell.ai/news/FLNA:1790095627808 2026-09-22T16:47:07.808Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/FDA-Warns-About-Salmonella-Risks.jpg?width=250&height=187 Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward Filana Therapeutics, Inc. (NASDAQ: FLNA) received a positive decision from the FDA, lifting a clinical hold on its investigational new drug application for simufilam, allowing the company to proceed with a Phase 2a clinical trial for Tuberous Sclerosis Complex-related epilepsy. The trial is set to begin screening patients by Q1 2027 and will involve 40 participants aged 12 to 55. Following the FDA's decision, Filana's stock price surged by 52.13% to $1.12. https://openbell.ai/news/PYPL:1790095508414 2026-09-22T16:45:08.414Z daily 0.9 https://cdn.brandfetch.io/PYPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud PayPal Collaborates With Meta For Clients To Shop, Check Out Through Muse Personal AI Agents PayPal has announced a collaboration with Meta to enable clients to shop and check out using Muse personal AI agents. This partnership aims to enhance the shopping experience by integrating AI technology into the payment process. Details regarding financial implications or specific terms of the collaboration were not disclosed. https://openbell.ai/news/PLTR:1790094997230 2026-09-22T16:36:37.230Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/New-York-City--New-York---September-3-20.jpg?width=250&height=187 Palantir Golden Cross Brings This Key Level Into Focus Palantir Technologies Inc (NASDAQ: PLTR) shares are currently trading at $183.81, up 0.40%, as they approach the upper end of a trading range between $166 and $188. The stock has shown a significant rally since early August, moving from around $125 to the mid-$160s, and recently crossed above its 50-day moving average, indicating a bullish trend. A decisive break above the $188 level could lead to a retest of its all-time closing high of $207.18 set on November 3 of last year. https://openbell.ai/news/AAPL:1790094907499 2026-09-22T16:35:07.499Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Beijing--China---July-21--2023-Apple-Log.jpg?width=250&height=187 Apple’s New Macs Are Faster, Smarter and Built for AI Apple Inc. has launched new Mac models, including the Mac mini and Mac Studio, featuring advanced M6 and M5 Pro chips, which offer up to four times faster AI performance and 40% faster CPU performance. The Mac mini starts at $899, while the Mac Studio begins at $2,499. Apple stock rose about 1% to $342.31, nearing its 52-week high of $344.57, as analysts express optimism about iPhone demand and the upcoming Duo foldable device, despite concerns over the company's high valuation at approximately 33 times fiscal 2027 earnings. https://openbell.ai/news/AMZN:1790094885704 2026-09-22T16:34:45.704Z daily 0.9 https://cdn.brandfetch.io/AMZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anthropic Introduces Claude Opus 5.5, Now Available On All Platforms, Including AWS, Google Cloud & Microsoft Azure; Claude Opus 5.5 Performs At Level Of Claude Fable 5.1 On Most Work, Costs Around 40% Less To Run Than Opus 5; Says Over Coming Weeks, We'll Also Be Launching Claude Sonnet 5.5 & Haiku 5.5 Anthropic has launched Claude Opus 5.5, which is now available on major platforms including AWS, Google Cloud, and Microsoft Azure. The new model performs comparably to Claude Fable 5.1 while being approximately 40% cheaper to operate than its predecessor, Opus 5. The company also plans to introduce Claude Sonnet 5.5 and Haiku 5.5 in the upcoming weeks. https://openbell.ai/news/AMZN:1790094683522 2026-09-22T16:31:23.522Z daily 0.9 https://cdn.brandfetch.io/AMZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amazon Web Services Now Available For Use By NATO Member Nations To Handle Restricted Workloads Amazon Web Services (AWS) has been approved for use by NATO member nations to manage restricted workloads. This development marks AWS as the first cloud provider to offer such services to NATO, potentially enhancing the cloud capabilities of member nations. The partnership is expected to facilitate secure data handling and improve operational efficiency within NATO operations. https://openbell.ai/news/BTCUSD:1790094467221 2026-09-22T16:27:47.221Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Los-Angeles--California---July-10-2025-B.jpg?width=250&height=187 EXCLUSIVE: 'Institutions Are Buying Bitcoin' — Retail Is Trading Everything Else Institutional interest in Bitcoin is increasing, with U.S. spot Bitcoin ETF assets under management rising from approximately $79 billion to $102 billion as of September 10, marking a $23 billion increase. Bitcoin's market dominance remains near 59%, indicating that institutional investments are becoming more concentrated in Bitcoin rather than spreading across the broader crypto market. In contrast, retail investors are gravitating towards meme coins, AI tokens, and tokenized stocks, with meme coins having a market cap of about $28.8 billion and daily trading volume of $3.5 billion. This divergence suggests a growing two-track market in the cryptocurrency space. https://openbell.ai/news/AAPL:1790094366815 2026-09-22T16:26:06.815Z daily 0.9 https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Apple Is Developing New Fitness Tracker Aimed at Rivaling Whoop' - Bloomberg News Apple is reportedly developing a new fitness tracker designed to compete with Whoop, a company known for its advanced health monitoring technology. This move indicates Apple's continued investment in the wearables market, aiming to enhance its product offerings in health and fitness. The development aligns with Apple's broader strategy to integrate health features into its ecosystem, potentially impacting its market position against competitors. https://openbell.ai/news/QTWO:1790094344303 2026-09-22T16:25:44.303Z daily 0.9 https://cdn.brandfetch.io/QTWO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Reiterates Overweight on Q2 Holdings, Maintains $82 Price Target Piper Sandler analyst Bill Carcache has reiterated an Overweight rating on Q2 Holdings (NYSE: QTWO) and maintained a price target of $82 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/CLDX:1790094318010 2026-09-22T16:25:18.010Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Asian-Woman-Facial-Skin-With-Red-Spots-A.jpg?width=250&height=187 Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease Celldex Therapeutics Inc. (NASDAQ: CLDX) announced positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 clinical trials for barzolvolimab, aimed at treating chronic spontaneous urticaria (CSU). The trials met both primary and secondary endpoints, showing significant improvements in disease activity and a favorable safety profile. The company plans to submit a Biologics License Application to the FDA in 2027. Following the announcement, Celldex shares fell by 12.51% to $36.65. https://openbell.ai/news/MU:1790094162731 2026-09-22T16:22:42.731Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Micron-Technology-Logo-Displayed-On-Sign.jpg?width=250&height=187 What Is Going on With Micron Stock on Tuesday? Micron Technology, Inc. (NASDAQ: MU) stock increased by over 6% on Tuesday, trading at $1,080.75, as investors prepared for its upcoming earnings report on September 30. Analysts anticipate quarterly revenue of $50.62 billion and adjusted earnings of $31.30 per share, driven by strong demand for AI memory. Additionally, Micron faces potential competition from China's CXMT, which has captured 9.5% of global DRAM revenue and is planning to develop NAND technology, although large-scale production remains uncertain. https://openbell.ai/news/MSI:1790093891508 2026-09-22T16:18:11.508Z daily 0.9 https://cdn.brandfetch.io/MSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Maintains Overweight on Motorola Solutions, Raises Price Target to $531 Piper Sandler analyst James Fish has maintained an Overweight rating on Motorola Solutions (NYSE: MSI) and increased the price target from $530 to $531. This adjustment reflects confidence in the company's performance and potential for growth. https://openbell.ai/news/PHAR:1790093768181 2026-09-22T16:16:08.181Z daily 0.9 https://cdn.brandfetch.io/PHAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Pharming (NASDAQ: PHAR) and maintained a price target of $37 for the stock. This endorsement reflects confidence in the company's performance and potential in the market. https://openbell.ai/news/CCL:1790093754008 2026-09-22T16:15:54.008Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/New-York--Usa---17-February-2021-Carniva.jpg?width=250&height=187 Why Is Carnival Stock Surging on Tuesday? Carnival Corporation Ltd. (NYSE: CCL) stock surged 2.80% to $22.93 on Tuesday, driven by declining crude oil prices and a broader rally in the airline and travel sectors. The company is set to release its third-quarter earnings on September 29, with analysts expecting earnings of $1.35 per share on revenue of $8.4 billion. Recent analyst ratings from Goldman Sachs and Stifel maintained Buy ratings but lowered price forecasts to $30 and $35, respectively. https://openbell.ai/news/NVDA:1790093576080 2026-09-22T16:12:56.080Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/AI-Chip-Smuggling-Cases.jpg?width=250&height=187 EXCLUSIVE: Small AI Model Matches GPT-4.1 at Forecasting as Olas Founding Member Says Frontier Models Face ‘Increasing Economic Pressure’ Olas has introduced a new AI model, Olas-Predict-R1-14B, which achieved 75.8% accuracy in predicting real-world events, surpassing OpenAI's GPT-4.1 at 75.4%. The model was trained on over 214,000 forecasts from prediction markets, indicating a trend where specialized AI models are exerting economic pressure on larger general-purpose models. CEO David Minarsch noted that smaller models could change the economics of AI demand, particularly as major tech companies are projected to spend over $886.7 billion on AI infrastructure by 2026. https://openbell.ai/news/CLDX:1790093499886 2026-09-22T16:11:39.886Z daily 0.9 https://cdn.brandfetch.io/CLDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $64 HC Wainwright & Co. analyst Joseph Pantginis has maintained a Buy rating on Celldex Therapeutics (NASDAQ: CLDX) and increased the price target from $42 to $64. https://openbell.ai/news/IONS:1790093467809 2026-09-22T16:11:07.809Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/22/Muscular-Dystrophy.jpg?width=250&height=187 Ionis to Seek Expedited FDA Review for ALS Drug Ionis Pharmaceuticals Inc. (NASDAQ: IONS) and Otsuka announced positive topline results from their Phase 3 FUSION trial for ulefnersen, an investigational treatment for amyotrophic lateral sclerosis (ALS) caused by FUS gene mutations. The trial met its primary endpoint, showing significant improvements in functional impairment and survival compared to placebo. Otsuka plans to discuss expedited FDA review pathways for ulefnersen, which is the first treatment targeting the genetic cause of FUS-ALS. Ionis shares rose 0.88% to $45.29, near their 52-week low.